Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vincerx Pharma, Inc. - Common Stock (NQ: VINC )

0.2305 -0.0048 (-2.04%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Vincerx Pharma, Inc. - Common Stock

< Previous 1 2 3 4 Next >
Why RAPT Therapeutics Shares Are Trading Lower By Over 30%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Ainos, Inc. (NASDAQ: AIMD) shares jumped 69.3% to $1.27 after the company announced it signed a Memorandum of Understanding with Merdury Biopharmaceutical to jointly explore and develop a... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Peering Into Vincerx Pharma's Recent Short Interest
Vincerx Pharma's (NASDAQ:VINC) short percent of float has fallen 6.62% since its last report. The company recently reported that it has 620 thousand shares sold short, which is 4.23% of all regular... 
Via Benzinga
5 Analysts Have This to Say About Vincerx Pharma
  Analysts have provided the following ratings for Vincerx Pharma (NASDAQ:VINC) within the last quarter: 
Via Benzinga
Analysts Cuts Price Target On This Small Cap But Remain Bullish
Via Benzinga
7 Analysts Have This to Say About Vincerx Pharma
Within the last quarter, Vincerx Pharma (NASDAQ:VINC) has observed the following analyst ratings: 
Via Benzinga
DSS And 3 Other Stocks Under $1 Insiders Are Aggressively Buying
The Dow Jones closed lower by over 100 points on Wednesday after the Fed raised interest rates by 50 bps. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Why Netcapital Shares Are Trading Lower By Over 33%? Here Are 50 Stocks Moving In Wednesday's Mid-Day Session
Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares rose 153% to $0.3325 after gaining 14% on Tuesday. Crown ElectroKinetics, last month, posted a Q3 loss of $0.18 per share. 
Via Benzinga
Small Cap Biotech Vincerx Cuts Third Of Staff
Cancer-focused biotech Vincerx Pharma Inc (NASDAQ: VINC) would lay off 33% of its staff to get its lead program through two Phase I studies. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 89 companies set new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  During Tuesday's trading, 160 companies set new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
  On Wednesday, 283 companies set new 52-week lows. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Imara (NASDAQ:IMRA) stock moved upwards by 37.2% to $3.54 during Friday's pre-market session. The market value of their outstanding shares is at $93.0 million. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers 
Via Benzinga
3 Stocks Under $2 Insiders Are Aggressively Buying
U.S. stock futures traded lower this morning on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern... 
Via Benzinga
The Daily Biotech Pulse: Veru Seeks Emergency Use Nod For COVID-19 Therapy, Vincerx Cuts Workforce, Moderna Starts Dosing In Flu Vaccine Study
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Why F45 Training Shares Climbed 41%; Here Are 84 Biggest Movers From Friday
Gainers FingerMotion, Inc. (NASDAQ: FNGR) gained 82.2% to close at $3.37. 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
  On Monday, 429 stocks made new 52-week lows. 
Via Benzinga
10 Biggest Price Target Changes For Tuesday
Keybanc cut Coupa Software Incorporated (NASDAQ: COUP) price target from $125 to $100. Coupa Software shares rose 0.9% to $72.74 in pre-market trading. 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
On Tuesday, 540 companies set new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
On Tuesday, 123 stocks made new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
On Monday, 198 companies reached new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
On Tuesday, 242 companies hit new 52-week lows. Noteworthy Mentions In Today's 52-Week Lows: The largest company in terms of market cap to set a new 52-week low was... 
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
On Thursday, 236 companies hit new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
On Monday, 466 companies hit new 52-week lows. Noteworthy Highlights From Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was... 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.